Pagana KD, Pagana TJ, Pagana TN. Mosby's Diagnostic and Laboratory Test Reference. 14th ed. St Louis, Mo: Elsevier; 2019.
Teixeira PC, Ducret A, Ferber P, Gaertner H, Hartley O, Pagano S, et al. Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases. J Biol Chem. 2014 Aug 28. [Medline].
Cochran BJ, Bisoendial RJ, Hou L, Glaros E, Rossy J, Thomas SR, et al. Apolipoprotein A-I Increases Insulin Secretion and Production From Pancreatic ß-Cells via a G-Protein-cAMP-PKA-FoxO1-Dependent Mechanism. Arterioscler Thromb Vasc Biol. 2014 Aug 21. [Medline].
Li XL, Li JJ, Guo YL, Zhu CG, Qing P, Wu NQ, et al. The Ratio of High-Density Lipoprotein Cholesterol to Apolipoprotein A-I Predicts Myocardial Injury Following Elective Percutaneous Coronary Intervention. Clin Cardiol. 2014 Aug 11. [Medline].
Rogacev KS, Zawada AM, Emrich I, Seiler S, Böhm M, Fliser D, et al. Lower Apo A-I and Lower HDL-C Levels Are Associated With Higher Intermediate CD14++CD16+ Monocyte Counts That Predict Cardiovascular Events in Chronic Kidney Disease. Arterioscler Thromb Vasc Biol. 2014 Sep. 34(9):2120-7. [Medline].
Mustad V, Derr J, Reddy CC, Pearson TA, Kris-Etherton PM. Seasonal variation in parameters related to coronary heart disease risk in young men. Atherosclerosis. 1996 Sep 27. 126(1):117-29. [Medline].
Xiao J, Borne Y, Bao X, et al. Comparisons of Risk Factors for Abdominal Aortic Aneurysm and Coronary Heart Disease: A Prospective Cohort Study. Angiology. 2021 Jan. 72 (1):24-31. [Medline]. [Full Text].
Henson D, Tahhan AS, Nardo D, Quyyumi AA, Venditto VJ. Association Between ApoA-I (Apolipoprotein A-I) Immune Complexes and Adverse Cardiovascular Events. Arterioscler Thromb Vasc Biol. 2019 Jul 18. ATVBAHA119312964. [Medline]. [Full Text].
Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA. 2003 Nov 5. 290(17):2292-300. [Medline].
Chiang SL, Ou TT, Wu YJ, Tu HP, Lu CY, Huang CM, et al. Increased level of MSU crystal-bound protein apolipoprotein A-I in acute gouty arthritis. Scand J Rheumatol. 2014 Sep 2. 1-5. [Medline].
Zhu W, Liu M, Wang GC, Peng B, Yan Y, Che JP, et al. Fibrinogen alpha chain precursor and apolipoprotein a-I in urine as biomarkers for noninvasive diagnosis of calcium oxalate nephrolithiasis: a proteomics study. Biomed Res Int. 2014. 2014:415651. [Medline]. [Full Text].